XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2B

XtalPi, a company that utilises AI to aid in the development and discovery of medicines, has raised $400 million in Series D, led by OrbiMed and RRJ, with a market value of more than $2 billion. The company offers its AI technology to pharmaceutical companies to boost their R&D and develop new drugs. AI-powered pharmaceutical company XtalPi has secured US$400 million…

XtalPi, which makes use of AI to aid in the development and discovery of medicines, has raised Series D 0M, which is led by OrbiMed and RRJ and RRJ, with a price of more than B (KrASIA). Source: Tech Meme

ai 400m orbimed rrj 2b